Linked Life Data

8383389

Source:http://linkedlifedata.com/resource/pubmed/id/8383389

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1993-4-8
pubmed:abstractText
In the industrialized countries of Europe, North America and Australia, the incidence and prevalence of hepatitis A decreased significantly during recent decades. In the high-endemicity areas of Africa, Asia and South America, hepatitis A is still transmitted during infancy or early childhood and usually leads to asymptomatic infection or only mild disease. The majority of infections in developed countries, however, now occur in young adults of whom 70-80% develop more severe icteric disease. Main risk groups in the latter regions are travellers to less-developed areas and drug addicts; an occupational risk of hepatitis A virus infection exists for individuals working in paediatric wards, in day-care centres, in medical laboratories/kitchens as well as for sewage workers. These individuals comprise the target group for active hepatitis A vaccination. Consequent use of these vaccines should not only prevent an often severe disease but also save significant costs.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0264-410X
pubmed:author
pubmed:issnType
Print
pubmed:volume
11 Suppl 1
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
S6-8
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:year
1993
pubmed:articleTitle
Adult use of hepatitis A vaccine in developed countries.
pubmed:affiliation
Institute for Medical Microbiology and Hygiene, University of Regensburg, Germany.
pubmed:publicationType
Journal Article